+ All Categories
Home > Documents > CRC Incidence, Mortality, and Survival in U.S.

CRC Incidence, Mortality, and Survival in U.S.

Date post: 06-Jan-2016
Category:
Upload: nyx
View: 32 times
Download: 2 times
Share this document with a friend
Description:
Colorectal Cancer Screening Update 2009 Maryland Dept. of Health and Mental Hygiene Center for Cancer Surveillance and Control Cigarette Restitution Fund Programs Unit. CRC Incidence, Mortality, and Survival in U.S. Annual age-adjusted cancer incidence rates, US, 1975-2004. - PowerPoint PPT Presentation
Popular Tags:
49
Colorectal Cancer Screening Update 2009 Maryland Dept. of Health and Mental Hygiene Center for Cancer Surveillance and Control Cigarette Restitution Fund Programs Unit
Transcript
Page 1: CRC Incidence, Mortality, and Survival in U.S.

Colorectal Cancer ScreeningUpdate 2009

Maryland Dept. of Health and Mental HygieneCenter for Cancer Surveillance and ControlCigarette Restitution Fund Programs Unit

Page 2: CRC Incidence, Mortality, and Survival in U.S.

CRC Incidence, Mortality, and Survival in U.S.

Page 3: CRC Incidence, Mortality, and Survival in U.S.

Annual age-adjusted cancer incidence rates, US, 1975-2004

CA Cancer J Clin Jemal et al. 58 (2): 71-96 (2008).

Page 4: CRC Incidence, Mortality, and Survival in U.S.

Annual age-adjusted cancer death rates--Males, US, 1930-2004

CA Cancer J Clin Jemal et al. 58 (2): 71-96 (2008).

Page 5: CRC Incidence, Mortality, and Survival in U.S.

Annual age-adjusted cancer death rates--Females, US, 1930-2004

CA Cancer J Clin Jemal et al. 58 (2): 71-96 (2008).

Page 6: CRC Incidence, Mortality, and Survival in U.S.

US SEER Sites: Five Year Relative Survival Rates by Race Colorectal Cancer

51% 59%66%

46% 49% 56%

0%

20%

40%

60%

80%

100%

1975-77 1984-86 1996-2004

Rela

tive

Perc

ent S

urvi

val

White African AmericanSource: SEER Cancer Statistics Review, 1975-2005. (Rates are from SEER 9 areas.)

Page 7: CRC Incidence, Mortality, and Survival in U.S.

CRC Screening

Page 8: CRC Incidence, Mortality, and Survival in U.S.

Colorectal Cancer Screening Status of People Age 50 Years and Older

Maryland Cancer Surveys, 2002-2008

22.616.9

10.111.0

19.8

25.9

10.3

41.2

22.8

50.3

10.5

58.7

8.6

7.1

17.7

66.6

0 10 20 30 40 50 60 70

Up-to-date with colonoscopy

Up-to-date with FOBT and/orsigmoidoscopy

Tested but not up-to-date*

Never tested

Percent

2002 2004 2006 2008

Page 9: CRC Incidence, Mortality, and Survival in U.S.

80% of people 50+ in 80% of people 50+ in Maryland reported having a Maryland reported having a provider provider recommend recommend endoscopy…..

of those, 88% got screened

88%

24%

0%

25%

50%

75%

100%

Providerrecommended

No providerrecommended

Percent Screened with Endoscopy

Source: Maryland Cancer Survey, 2008

Provider Recommendation is KEY to Screening

Of the 20% who did NOT report a provider recommendation….only 24% got screened

Page 10: CRC Incidence, Mortality, and Survival in U.S.

Colorectal Cancer Colonoscopy or Sig.

(50+ years)

Never screenedwith col. or sig.

25%

Ever screened with col. or sig.

Source: Maryland Cancer Survey, 2008

Page 11: CRC Incidence, Mortality, and Survival in U.S.

Colorectal Cancer Colonoscopy or Sig.

(50+ years)

Never screenedwith col. or sig.

25%

Ever screened with col. or sig.

85% 85% have been to doctor have been to doctor

for “routine checkup”for “routine checkup” in past 2 yearsin past 2 years

Only 15%have NOT had checkup

Source: Maryland Cancer Survey, 2008

Page 12: CRC Incidence, Mortality, and Survival in U.S.

Patient:Family and personal historyPast screeningSymptoms

Primary Doctor:Referral

Pathologist:Pathology report

Case Management and Communication

Colonoscopist:Risk historyMedication changesPrep instructionsPost colonoscopy instructionsColonoscopy report

FindingsRecommendations

Page 13: CRC Incidence, Mortality, and Survival in U.S.

Who needs screening?Who needs screening?

Page 14: CRC Incidence, Mortality, and Survival in U.S.

Colorectal Cancer Rates by Age and SexCancers of the Colon and Rectum:

Average Annual Age-Specific SEER Incidenceand U.S. Mortality Rates by Gender, 2001-2005

Source: SEER Cancer Statistics Review 1975-2005. Colon and Rectum Cancer, SEER Incidence and U.S. Death Rates, Age-Adjusted and Age-Specific Rates, By Race and Sex (Rates based on SEER 17 areas)

0

100

200

300

400

500

30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85+

Age Group

Nu

mb

er

pe

r 1

00

,00

0

Incidence Men

Incidence Women

MortalityMen

MortalityWomen

Age recommended to start screening

Page 15: CRC Incidence, Mortality, and Survival in U.S.

Colorectal Cancer Mortality Rates by Race and Sex in Maryland, 1998-2005

Age-adjusted rate per 100,000 population

Source: NCHS Compressed Mortality File in CDC Wonder

0

10

20

30

40

50

1998 1999 2000 2001 2002 2003 2004 2005

White men

Black women

White women

Black men

Page 16: CRC Incidence, Mortality, and Survival in U.S.

Colorectal Cancer Cases by Risk History

Sporadic Sporadic (average risk) (65%–85%)(average risk) (65%–85%)

FamilyFamilyhistoryhistory(10%–30%)(10%–30%)

Hereditary nonpolyposis Hereditary nonpolyposis colorectal cancer colorectal cancer

(HNPCC) (5%)(HNPCC) (5%)Familial adenomatous Familial adenomatous polyposis (FAP) (1%)polyposis (FAP) (1%)

Rare Rare syndromes syndromes

(<0.1%)(<0.1%)

(84,600-110,670 cases/yr.)(84,600-110,670 cases/yr.)

Page 17: CRC Incidence, Mortality, and Survival in U.S.

Risk of CRCGroup Approx. lifetime risk of CRC

General Population 5-6%

One first degree relative (FDR) with CRC 2--3-fold increased over general population

Two FDRs with CRC 3--4-fold increased

FDR with CRC diagnosed < 50 3--4-fold increased

One second or third degree relative About 1.5-fold increased

Two second degree relatives About 2--3-fold increased

One FDR with adenoma About 2-fold increased

Inflammatory Bowel Disease (ulcerative colitis and Crohn colitis)

[7-10% have CRC after having ulcerative colitis for 20 years; then ~1%/year]

Familial Adenomatous Polyposis

Hereditary Non-polyposis Colorectal Cancer

~100%

~80+%

Burt. Gastroenterology 2000;119:837-53 Winawer et al. Gastroenterology 203;124:544-560

Page 18: CRC Incidence, Mortality, and Survival in U.S.

Risk Category Age to Begin ScreeningAverage risk 50 years

Increased risk

Family history (first degree relative with CRC or adenoma)

40 years old or 10 years before the youngest case in the family

Genetic syndrome:

FAP

HNPCC

Puberty

21 years old

Inflammatory bowel disease

8 years after start of pancolitis;

12-15 years after start of left sided colitis

Page 19: CRC Incidence, Mortality, and Survival in U.S.

Average Risk

Increased Risk

Colonoscopy, every 10 years orFOBT annually, plus Flex sig., every 5 years

FOBT if refuse endoscopy

Colonoscopy(interval for repeat depends on risk, history, and prior results)

Maryland Screening Recommendations:Medical Advisory Committee on CRC

Page 20: CRC Incidence, Mortality, and Survival in U.S.

New Guidelines

Screening and Surveillance for the Early Detection of Colorectal Cancer and

Adenomatous Polyps, 2008:

A Joint Guideline from the American Cancer Society,

the US Multi-Society Task Force on CRC, and the American College of Radiology

CA Cancer J Clin 58: 130-160 (May 2008)

Page 21: CRC Incidence, Mortality, and Survival in U.S.

Bernard Levin, David A. Lieberman,

Beth McFarland, Robert A. Smith, Durado Brooks,

Kimberly S. Andrews, Chiranjeev Dash,

Francis M. Giardiello, Seth Glick,

Theodore R. Levin, Perry Pickhardt, Douglas K. Rex, Alan Thorson,

Sidney J. Winawer, for the American Cancer Society Colorectal Cancer Advisory Group,

the US Multi-Society Task Force, and the American College of Radiology Colon Cancer Committee

Page 22: CRC Incidence, Mortality, and Survival in U.S.

Tests that Find Both Polyps and Cancer

Flexible sigmoidoscopy every 5 years 

Colonoscopy every 10 years 

Double contrast barium enema every 5 years 

CT colonography (virtual colonoscopy) every 5 years

New Guidelines American Cancer Society, May 2008

Page 23: CRC Incidence, Mortality, and Survival in U.S.

Tests that Primarily Find Cancer

Guaiac-based fecal occult blood testing (gFOBT) every year 

Fecal immunochemical test (FIT) every year 

Stool DNA test (unclear how often this is needed)

New Guidelines American Cancer Society, May 2008

Page 24: CRC Incidence, Mortality, and Survival in U.S.

New CRC Screening Guidelines American Cancer Society, May 2008

• Beginning at age 50, men and women at average risk for CRC should use one of the screening tests

• The tests that are designed to find both early cancer and polyps are preferred if these tests are available to you and you are willing to have one of these more invasive tests.

• Talk to your doctor about which test is best for you.

Page 25: CRC Incidence, Mortality, and Survival in U.S.

CRC Screening Program in Maryland

Page 26: CRC Incidence, Mortality, and Survival in U.S.
Page 27: CRC Incidence, Mortality, and Survival in U.S.
Page 28: CRC Incidence, Mortality, and Survival in U.S.
Page 29: CRC Incidence, Mortality, and Survival in U.S.

Summary of Cigarette Restitution FundSummary of Cigarette Restitution FundColorectal Cancer Screening in MarylandColorectal Cancer Screening in Maryland

As of December 31, 2008:

16,737 16,737 People have had one or more People have had one or more screening proceduresscreening procedures

____________________________________________________________________________

8,328FOBTs (all income levels)FOBTs (all income levels) 148SigmoidoscopiesSigmoidoscopies13,552ColonoscopiesColonoscopies

Source: DHMH, CCSC, Client Database (CDB), C-CoPD, C-CoP, as of 2/11/2009

Page 30: CRC Incidence, Mortality, and Survival in U.S.

Summary of Cigarette Restitution FundSummary of Cigarette Restitution FundColorectal Cancer ScreeningColorectal Cancer Screening

________ County, Maryland________ County, Maryland

2000-2008:

XXXX Individuals screened for CRC Individuals screened for CRC by one or more methodby one or more method++

____________________________________________________________

XXXX FOBTs* FOBTs*XX Colonoscopies*XX Colonoscopies*____________________________________________________________

XX Cancers* Cancers* X High grade dysplasia*X High grade dysplasia* XX Adenoma(s)*XX Adenoma(s)*

+Source: DHMH, CCSC, Client Database (CDB), C-CoPD, as of 2/11/2009*Source: DHMH, CCSC, Client Database (CDB), C-CoP, as of 2/11/2009

Obtain numbers for y

our jurisdiction

from th

e chart presented at th

e

teleconference 2/18/2009 CCSC HO

Memo 09-08, Atta

chment 5, o

r call

Lorraine Underwood 410-767-0791

Page 31: CRC Incidence, Mortality, and Survival in U.S.

Gender of 17,035 Screened* for CRC Maryland 2000-December 2008

*Of clients screened with one or more of the following: FOBT, Flex sig, colonoscopy, DCBE

Women11,673(68%)

Men5,332(31%)

Source: DHMH, CCSC, Client Database (CDB), C-CoP, as of 1/14/2009

Page 32: CRC Incidence, Mortality, and Survival in U.S.

Minority Status of 16,711 New People Screened* for CRC, Maryland 2000-December 2008

*Of clients screened with one or more of the following: FOBT, Flex sig, colonoscopy, DCBE

Non-minority8,539 (51%)

Minority8,172 (49%)

Source: DHMH, CCSC, Client Database (CDB), C-CoPD, as of 1/14/2009

Page 33: CRC Incidence, Mortality, and Survival in U.S.

Results* of 13,507 Colonoscopies Maryland Cigarette Restitution Fund Program

Maryland 2000-December 2008

* Most “advanced” finding on colonoscopySource: DHMH, CCSC, Client Database (CDB), C-CoP, as of 1/12/2009

Other polyps, 2843, 21%Other f indings,

4946, 38%

Adenoma Hi-Grade, 53, 0%

Inadequate col but no f indings, 186, 1%

Cancer/Suspected Cancer, 152, 1%

Negative, 2351, 17% Adenomas, 2976,

22%

Page 34: CRC Incidence, Mortality, and Survival in U.S.

Recommended screening afterafter initial screening--

rescreening or surveillance colonoscopy

“Recall Interval”

Page 35: CRC Incidence, Mortality, and Survival in U.S.

After first colonoscopy, then whatthen what?

• Interval between colonoscopies will depend on:

– findings,

– risk history, and

– symptoms

Page 36: CRC Incidence, Mortality, and Survival in U.S.

Interval between colonoscopies

IF IF Findings on colonoscopy were negative:– No CRC;

– No adenomas; and

– No or only a few hyperplastic polyps,

Average risk, and

No CRC symptoms

• Interval will usually be 10 years • See guidelines for recommended interval

Page 37: CRC Incidence, Mortality, and Survival in U.S.

Interval between colonoscopies– based on findings

IF Findings showed:• Inadequate colonoscopy

– didn’t reached cecum– inadequate bowel preparation

• Cancer • Adenomatous polyp(s)—need to know:

– Number– Size– Histology– Completeness of removal

• Many hyperplastic polyps indicating Hyperplastic Polyposis Syndrome

• Interval will usually be LESS THAN 10 years • See guidelines for recommended interval

Page 38: CRC Incidence, Mortality, and Survival in U.S.

Interval between colonoscopies– based on risk history

IF first colonoscopy was negative BUT person is at increased risk because of family history:

• Interval may be LESS THAN 10 years

• See guidelines for recommended interval

Page 39: CRC Incidence, Mortality, and Survival in U.S.

Example

• 53 year old patient had a colonoscopy:

“several adenomas were found”

What is the recommended recall interval? What else do you need to know to determine

the interval?Who will tell the patient?Will anyone remind the patient when the next

colonoscopy is needed?

Page 40: CRC Incidence, Mortality, and Survival in U.S.

• Was the bowel preparation adequate?

• Was the cecum reached?

• How many adenomas were found?

• How big were the adenomas?

• Were they completely removed?

• What was the pathology?

• What is the family and personal risk history of the patient?

Answer:Answer: You need to know more about the Risk and You need to know more about the Risk and Colonoscopy Results Colonoscopy Results beforebefore you can set the right you can set the right recall interval:recall interval:

Page 41: CRC Incidence, Mortality, and Survival in U.S.

Guidelines for Colonoscopy Surveillance after polypectomy--Winawer et al. CA--A Cancer Journal for Clinicians 56 (3) 143. (2006)

http://caonline.amcancersoc.org/

Page 42: CRC Incidence, Mortality, and Survival in U.S.

Recall Interval Based on Finding of First Colonoscopy

Finding Interval

“Inadequate” bowel prep

(How inadequate was it?)

Repeat right away or do other screening (e.g., DCBE)

Didn’t reach or view cecum Repeat right away or do other screening to check cecum

“Two adenomas” Need to know histology and size

Any villous histology (villous, tubulovillous) or high grade dysplasia

If completely removed, repeat in 3 years

One or more adenomas >1 cm in size

Repeat in 3 years

Incomplete removal of adenomas Consider short recall interval (2-6 months)

1-2 tubular adenomas, <1 cm size Repeat in 5-10 years

Page 43: CRC Incidence, Mortality, and Survival in U.S.

Keys to the right recall

1. Colonoscopy Report

2. Pathology Report

3. Recommendation based on guidelines

4. Communication

Page 44: CRC Incidence, Mortality, and Survival in U.S.

Standards for Colonoscopy Reports--CoRADS*

• Date and Time Procedure 

• Patient description • Risk factors-• ASA class • Indications• Consent signed • Sedation  • Colonoscope • Bowel Prep • Reached cecum 

• Colonoscopy withdrawal time 

• Findings• Specimen(s) to path lab • Impression • Complications • Pathology • Recommendations, • Follow-up Plan/Recall • Other 

* Standardized colonoscopy reporting and data system (CoRADS): report of the Quality Assurance Task Group of the National Colorectal Cancer Roundtable, Lieberman et al., Gastrointestinal Endoscopy 2007; 65: 757-766

Page 45: CRC Incidence, Mortality, and Survival in U.S.

Adequacy of First ColonoscopyAmong 10,328* Cycle 1 Colonoscopies

Maryland 2000-December 2008

*10,328 of the 11,421 first colonoscopies had information on “adequacy” of the col.

Source: DHMH, CCSC, Client Database (CDB), Ad-hoc report, 1/12/2009

Adequate 9,468, 92%

Not Adequate (inadequate

prep OR didn't reach cecum)

860, 8%

Page 46: CRC Incidence, Mortality, and Survival in U.S.

Reporting on

Colonoscopy Findings: – Number of masses, polyps, other lesions

• (try to give actual or estimated number rather than “several” or “multiple”)

– Findings: for EACH mass/polyp/lesion--

locationsize description tattoo biopsy(ies) taken method of each biopsywhether lesion completely removed or not

whether there was piecemeal removal whether specimens retrievedwhether saline lift usednumber of specimens sent to pathology

Page 47: CRC Incidence, Mortality, and Survival in U.S.

How will your patients be reminded about their next next colonoscopy?

Page 48: CRC Incidence, Mortality, and Survival in U.S.

Patient:Family and personal historyPast screeningSymptoms

Primary Doctor:Referral

Pathologist:Pathology report

Case Management and

Communication

Colonoscopist:Risk historyMedication changesPrep instructionsPost colonoscopy instructionsColonoscopy report

FindingsRecommendations

Page 49: CRC Incidence, Mortality, and Survival in U.S.

Acknowledgements

--Funding from the Maryland Cigarette Restitution Fund

--Staff and partners of Local Public Health Department Programs in MD and their contracted providers

-- DHMH Center for Cancer Surveillance and Control (CCSC)Database and Quality assurance-Surveillance and Epidemiology Unit

- University of Maryland at Baltimore- Ciber, Inc.

- CCSC CRF Programs Unit

-- DHMH FHA, Information Technology

-- Minority Outreach Technical Assistance Partners


Recommended